Expression of nestin has been suggested to be a characteristic of pancreatic islet stem cells. To determine whether nestin is indeed expressed in such putative cells during embryonic development, or in the adult pancreas after injury, we performed a cell lineage analysis using two independent lines of transgenic mice encoding Cre recombinase under the control of rat nestin cis-regulatory sequences, each crossed with loxP-bearing R26R mice. F1 animals produced the reporter molecule b-galactosidase only upon Cre-mediated recombination, thus solely in cells using (or having used) the transgenic nestin promoter. In early pancreatic primordia, b-galactosidase was observed in mesenchymal and epithelial cells. At later developmental stages or in adults, vast clusters of acinar cells and few ductal cells were labeled, in addition to fibroblasts and vascular cells, but no endocrine cells were tagged by b-galactosidase. This correlated with the transient expression, observed with an anti-nestin antibody, of endogenous nestin in about 5% of epithelial cells during development (whether in cord-forming arrangements or in nascent acini), and in vascular and mesenchymal structures. After partial pancreatectomy, there was a transient increase of the number of anti-nestin-labeled endothelial cells, but again, no endocrine cells bore b-galactosidase. Together, these findings show that nestin is expressed in the pancreatic exocrine cell lineage, and suggest that consistent nestin expression is not a major feature of islet endocrine progenitor cells. q
Introduction
The isolation of islet or pancreas stem cells requires the identification of molecular markers characteristic of such lineage precursors. During murine embryogenesis, the pancreas begins to develop at embryonic day E9.5 from evaginations of the endoderm at the level of the anterior intestinal portal (AIP), forming two primordia (dorsal and ventral) capped by mesenchymal cells (Pictet et al., 1972; Wells and Melton, 1999) , which are subsequently brought together to form a single gland. Proliferation of the pancreatic epithelial endoderm results in the formation of a tubular complex from which clusters of endocrine and exocrine cells progressively differentiate (Herrera et al., 1991; Slack, 1995) . The four main pancreatic endocrine cell types (b, a, d and PP cells, which produce insulin, glucagon, somatostatin and pancreatic polypeptide, respectively) arise from epithelial progenitor cells that can be identified for their expression of transcription factor Ngn3 (Gu et al., 2002; Herrera et al., 2002) . In adult mice, pancreatic stem cells seem to reside in the ducts and within the islets (Bonner-Weir and Sharma, 2002) ; nevertheless, it is not known whether they are Ngn3 þ , and no marker for such putative precursor/stem cell has been identified so far. Since pancreatic and intestinal endocrine cells share many markers with neuronal cells, namely: peptidic hormones, neuropeptide-processing enzymes, glucose transporters, transcription factors (Ngn3, Pax-4, Pax-6, Isl1, NeuroD/ Beta2, Nkx 2.2 and Nkx 6.1) (Ahlgren et al., 1997; Alpert et al., 1988; Gradwohl et al., 2000; Naya et al., 1997; Sander et al., 2000; Sosa-Pineda et al., 1997; Sussel et al., 1998; Turque et al., 1994) , among others, it was thought that the Class IV intermediate filament nestin, a specific marker of neuronal stem cells (Cattaneo and McKay, 1990; Johansson et al., 1999; Lendahl et al., 1990) , which is widely expressed during development but is very rare in adult organs, could be a marker of islet progenitor cells as well (Hunziker and Stein, 2000) . Nestin has been detected in many proliferating regions of the central nervous system (CNS) and in developing mesenchyme and blood vessels throughout the embryo (Dahlstrand et al., 1995; Frojdman et al., 1997; Kachinsky et al., 1994 Kachinsky et al., , 1995 Nemecek, 1998a,b, 1999; Yang et al., 2000) , where it could be involved in epithelium-mesenchymal interactions (About et al., 2000) and in cell migration (Doyle et al., 2001) . Whether nestin is a marker of a multipotent pancreatic stem cell population is debated (Blyszczuk et al., 2003; Duvillie et al., 2003; Klein et al., 2003; Lardon et al., 2002; Lumelsky et al., 2001; Selander and Edlund, 2002; Zulewski et al., 2001) . Nestin has been reported in cells located within adult pancreatic islets (Hunziker and Stein, 2000) ; when isolated, these nestin-positive cells can be grown ex vivo into different pancreatic cell types (Zulewski et al., 2001) . Others reported that ES cells selected for their expression of nestin can differentiate in vitro into the four islet endocrine cell types (Lumelsky et al., 2001) . Taken together, these results have suggested that nestin-positive cells represent a multipotent pancreatic stem cell population, which could be used in future cell replacement therapies to cure diabetes. However, other experimental evidences have toned down the hope of generating new b-cells from such hypothetical nestinpositive precursors. Nestin has been shown by immunohistochemistry to be expressed in mesenchymal cells during pancreatic development, but not in epithelial cells of the developing mouse pancreas (Klein et al., 2003; Lardon et al., 2002; Selander and Edlund, 2002) , where the islet cells form, whereas in the pancreas of adult mice nestin was only found in stellate and endothelial cells (Lardon et al., 2002) . Other reports failed to reproduce the results obtained with nestin-enriched ES cells (Rajagopal et al., 2003) .
In this study we sought to determine whether islet endocrine cells derive from nestin-expressing progenitors. We thus have systematically analyzed in vivo, during embryogenesis and in adulthood, the progeny of cells that transcribe the nestin gene by marking them genetically using the Cre/loxP approach (Gannon et al., 2000; Gu et al., 2002 Gu et al., , 2003 Herrera, 2000; Herrera et al., 1998 Herrera et al., , 2002 Kawaguchi et al., 2002) . Briefly, in doubly transgenic mice (nestin-Cre/R26R), the cells transiently (or permanently) expressing nestin also produce Cre and are genetically tagged, at the Rosa26 locus (R26R mice, Soriano, 1999) , so that their progeny stably expresses the b-galactosidase reporter. We found that nestin is expressed not only in mesenchymal tissues but also in epithelial cells of the exocrine lineage, and that islet endocrine cell progenitors do not express this marker.
Results

1.
Nestin is expressed in mesenchymal and epithelial cells of the developing pancreas (Fig. 1) . In order to determine whether nestin is expressed during pancreas development we used an anti-mouse nestin monoclonal antibody. At the earliest stage analyzed, E10.5, mesenchymal stained cells were abundant around the pancreatic primordia (not shown). At E12.5, stained cells were frequent in the mesenchyme surrounding the branching primordium, as described (Klein et al., 2003; Selander and Edlund, 2002) (Fig. 1B,C) ; however, contrary to previous reports (Hunziker and Stein, 2000; Klein et al., 2003; Lardon et al., 2002; Selander and Edlund, 2002; Piper et al., 2002) , nestin-positive cells forming clusters within the growing epithelial cords were also found: 5.7% of the epithelial cells were nestin-positive (Figs. 1B,C,4G ). At E15.5 and E17.5, anti-nestin antibody clearly labeled mesenchyme and vessels (Fig. 1E,F ,H) as well as some acini (Fig. 1E,F,H ), but no staining was ever seen in nascent islets (Fig. 1I) . The proportion of nestin-expressing epithelial cells decreased as differentiation progressed (3.9% at E15.5, 0.2% at E17.5), so that after birth, nestinexpressing epithelial cells were absent (Fig. 4G) .
2. The expression pattern of the two nestin-Cre transgenes accurately reflects that of endogenous nestin gene (Figs. 2,3 ). Nestin-expressing cells and their progeny were traced in vivo using the Cre/loxP system, as in previous pancreatic cell lineage analyses (Gannon et al., 2000; Gu et al., 2002; Herrera, 2000; Herrera et al., 1998 Herrera et al., , 2002 Kawaguchi et al., 2002) (Fig. 2) . We used two different transgenic strains of mice, encoding Cre under the control of rat nestin cis-regulatory sequences, which were generated independently in different laboratories (Tronche et al., 1999; Trumpp et al., 1999) . Both yielded the same expression pattern, indicating that the phenotype was likely not affected by the integration site and the number of copies of the transgenes. Throughout development, doubly transgenic embryos displayed a fully penetrant expression of the reporter b-galactosidase gene in the central nervous system and in other organs such as the eyes, vessels and hair follicles (Fig. 3A ,B,D,E), where nestin expression has been demonstrated by immunostaining (Kachinsky et al., 1995; Li et al., 2003; Mokry and Nemecek, 1998b; Yang et al., 2000) . In early pancreatic primordia (E10.5 -12.5), bgalactosidase was found in cells that were stained with antinestin antibody, indicating that the activity of nestin-Cre transgenes is accurate (Fig. 3F,G) . Nestin-expressing cells were slightly more abundant than X-Gal þ cells (5.7 vs. 4.8% in the epithelia, respectively-see below); since there is a delay of several hours between Cre expression and activation of the recombined reporter transgene (Davidson et al., 2003) , an early population of pancreatic nestin þ precursor cells might not be X-Gal-labeled in the buds of E10.5-12.5 transgenic embryos. Later and post-natally, the proportion of b-galactosidase þ cells increased (see below), concomitantly with a decrease to almost total dismiss of anti-nestin-labeling, since b-galactosidase expression, once triggered, is irreversible (Fig. 2) .
3. The reporter b-galactosidase transgene is activated in mesenchymal and epithelial cells of early pancreatic primordia, but not in endocrine cells (Figs. 4, 5) . We started the systematic analysis of X-Gal staining at E12.5. At this stage, the blue labeling was observed in mesenchymal and vascular cells, as well as in 4.8% of epithelial cells (Fig. 4A,G) , which correlates with the expression of endogenous nestin, as shown above. From E15.5 to adulthood, the proportion of stained epithelial/acinar cells, which were distributed within the entire gland, increased from 6.5 to almost 20% (Figs. 4B -G,5D,6C). Frequently, within stained acini, not all cells bore b-galactosidase (Fig. 4E ). Excretory ducts, mesenchymal and vascular cells were also stained (Fig. 4) . Within the islets, no staining was found (Fig. 4F) . By combining X-Gal staining and immunohistochemistry, we performed a precise identification of traced cells. Islet endocrine cells were not labeled ( Fig. 5A -C ). X-Gal þ cells were stained with anti-amylase (acinar cells, Fig. 5D ), anticytokeratin (ducts), anti-vimentin (fibroblasts), and antimyosin or anti-pecam (blood vessels) antibodies (not shown). That hormone-containing endocrine cells were never X-Gal þ indicates that they had not been tagged by Cre expression, and suggests that neither they nor their progenitors express significant amounts of nestin.
4. Pancreas remodeling after partial pancreatectomy is characterized by a transient over-expression of endothelial nestin (Fig. 6) . In order to determine whether expression of nestin is a feature of the cells that generate new endocrine cells during islet neogenesis in the adult pancreas, we performed a partial pancreatectomy of about 60% of the gland (Bonner-Weir et al., 1983) in four wild type mice and in four nestin-Cre/R26R animals (two of each strain), and the pancreatic remnants (which correspond to the duodenal pancreas) were quantitatively analyzed either 1, 3 or 13 days after the operation, or 1 month later. The nestin-Cre/R26R transgenics were only analyzed 13 or 30 days post-surgery, when the process of regeneration has been completed. In the adult pancreas, occasional nestin-expressing endothelial cells were observed (Fig. 6A) . After partial pancreatectomy, the number of cells stained with anti-nestin antibody in the remaining pancreas increased dramatically starting 3 days post-removal, both in islets and in the exocrine parenchyma (Fig. 6A,B ). Thirty days after pancreatectomy the antinestin staining pattern was indistinguishable from that of non-operated pancreata (Fig. 6A) , showing the transitory character of the increase in nestin expression. The nestinexpressing cells, whether within the islets or amongst the acini, were revealed to be endothelial with anti-pecam staining (Fig. 6B) . In nestin-Cre/R26R mice, the proportion of cells having expressed the nestin-Cre transgenes (i.e. having b-galactosidase) after partial pancreatectomy was similar to that in non-operated controls (Fig. 6C) , and no islet endocrine cell was stained using anti-b-galactosidase antibody or the substrate X-Gal, indicating that cells having expressed the nestin gene contribute to adult pancreas remodeling to a similar extent as during embryonic development.
Discussion
Tracking the progeny of a particular cell in transgenic mice expressing Cre recombinase is an informative approach with broad potential applications. The direct pancreatic cell tracing experiments reported herein suggest two main conclusions: first, about one-fifth of adult exocrine cells descend from nestin-expressing progenitors, and second, nestin is probably not a general marker of the endocrine lineages. Furthermore, after partial pancreatectomy, nestin is transiently expressed in endothelial cells that are probably involved in tissue remodeling.
Tracking the fate of cells in vivo: limitations of transgenesis. In this study we used two different, previously generated, nestin-Cre transgenic strains (Tronche et al., 1999; Trumpp et al., 1999) . The pattern of b-galactosidase activity was the same in both cases, which strengthens the conclusions supported by our observations. Nevertheless, since the nestin regulatory elements used are incomplete, Cre expression may not accurately recapitulate the entire pattern of endogenous nestin expression in the embryo; in the early developing pancreas, however, all X-Gal þ cells were stained with anti-nestin antibody. General strategy used to irreversibly label cells using the nestin regulatory elements. In doubly transgenic mice, if a progenitor cell expresses nestin, whether transiently or not, then it should also express the transgenic Cre, which would induce the irreversible excision of the floxed STOP sequence at the R26R locus, thus allowing the expression of b-galactosidase in that particular cell, and in its progeny, and therefore the tracing of its lineage. Fig. 3 . The nestin cis-regulatory sequences-driven transgenes express Cre accurately. (A -C) X-Gal-staining in whole mount embryos. Cre activity corresponds to nestin expression in early E10.5 nestin-Cre/R26R embryos, in which the encephalon and neural tube were deeply stained in the presence of X-Gal, as described (Zimmerman et al., 1994 ) (A). At E15.5, the retina, hair follicles (double arrow) and blood vessels (arrow) were clearly stained (B), as well as many cells in the pancreas (C). (D,E) Sagittal (D) and transverse (E) sections of the neural tube (developing spinal cord, E10.5) at the level indicated with a box in panel A. b-Galactosidase activity (D) and anti-nestin antibody (E) marked the ependymal layer (e), which is very thick at this early stage. (F,G) Doubly transgenic E12.5 pancreatic buds were double-stained using X-Gal (pale blue) and anti-nestin antibody (brown). In these sections, endogenous nestin and b-galactosidase were detected in the same cells. An arteriole (F) and mesenchymal cells (G) are shown. Scale bars, 0.5 mm (A -C) and 20 mm (D-G). a, amnion; c, central canal (neural lumen); d, duodenum; da, dorsal aorta; dp, dorsal pancreas; e, ependymal layer; m, muscle; vp, ventral pancreas.
The main limitation of classical transgenesis by pronuclear microinjection of DNA into zygotes is variegation, i.e. reliability of transgene expression, which is site-and copy number-dependent, even within the same litter.
Transgene silencing (loss of expressivity) may result from a number of alterations, whether genetic (intra-locus recombination, when there is a high number of tandem copies) or epigenetic (hypermethylation). For this reason, this technique requires the production of large numbers of founder mice; in most cases, these allow for the selection of good strains in which there is reproducible transgene expression, without aberrant activity.
More recently, new approaches, such as the use of very large stretches of DNA in bacterial artificial chromosomes (BACs) comprising entire enhancer/promoter sequences, or the generation of knock-in mice, may help overcome the problems of accuracy in transgene expression. In both cases, homologous recombination is used to replace or modify, by introducing the transgenic DNA, the transcribed region of the gene whose regulatory sequences are to be used in the transgenic animal. Even though the generation of knock-in nestin-Cre mice would probably be the best solution to address the Cre expression concerns, these techniques have their own problems, as for classical transgenes, since genes may have unknown internal regulatory elements that are replaced, or split, or altered somehow by the inserted foreign DNA. In other situations, which may not apply to nestin, the generation of knock-in mice may not be the best solution, such as for genes located on the X chromosome, or parentally imprinted, or expressed monoallelically, or even for those genes whose normal activity is only obtained when both alleles are expressed.
Nestin is expressed in pancreatic epithelial cells. The expression pattern of nestin in the pancreas is controversial. The detection of nestin transcripts in early pancreatic bud cells (E12.5 total RNA) was recently reported in gene expression profiling analyses (Chiang and Melton, 2003) . The presence of nestin has been described, by immunohistochemistry, in islet cells that do not contain hormones (Hunziker and Stein, 2000; Zulewski et al., 2001) or in some ductal cells (Zulewski et al., 2001) or only in mesenchymal cells surrounding the developing gland (Selander and Edlund, 2002) . Other studies on adult pancreata show that pancreatic nestin is found in capillaries (Klein et al., 2003) and also in pericytes after duct ligation, or during development (Lardon et al., 2002) . Our observations using anti-mouse nestin antibody confirm that nestin is much more abundant in the developing pancreas than in the adult, and is mainly expressed in mesenchymal and vascular cells (Klein et al., 2003; Lardon et al., 2002; Selander and Edlund, 2002) . However, we show, together with the accompanying paper by Esni and co-workers, that nestin is also expressed in early epithelial cords and, later in development, in some acini as well as in ductal cells. That nestin is expressed in certain epithelial cells during development has been demonstrated in other organs such as the mesonephros, eye and hair follicles (Frojdman et al., 1997; Mokry and Nemecek, 1998b) . The difference with previous reports on pancreatic primordia probably reflects the different sensitivity of the antibodies or the immunohistochemical techniques used.
We have reported that some 20% acinar (and ductal) cells are labeled in the adult nestin-Cre/R26R mice. Whereas Esni and colleagues (this issue) have obtained very similar results with pancreatic primordia grown in vitro, this observation is discordant with a recently published report (Treutelaar et al., 2003 ) also using the nestin-Cre mice generated by one of us (Trumpp et al., 1999 , which is one of the two strains used in this study). The reason for this discrepancy is not clear at this time.
Between E15.5 and adult life, i.e. in a period where nestin is not expressed, the proportion of epithelial cells that express b-galactosidase increases from 6.5 to 20%. This observation suggests that, for some reason, the progeny of nestin þ cells has a proliferative advantage as compared with that of epithelial cells not expressing nestin. It is noteworthy that, in the majority of X-Gal þ acini, only a fraction of acinar cells were stained, suggesting that in vivo, acini, as islets (Deltour et al., 1991) , have a polyclonal origin (Percival and Slack, 1999) ; alternatively, a nestinnegative early acinar progenitor may give rise to nestin þ and nestin 2 progeny in some acini. The biological significance of these acinar and ductal cell populations derived from nestin-expressing progenitors is not clear at this time, and they do not appear to contribute to adult regeneration differently than non-stained acini. Indeed, whether these tagged exocrine cells represent a versatile population of cells that, by transdifferentiation, could directly contribute to the rise of new endocrine cells during regeneration after injury seems unlikely, since our results using a model of partial pancreatic ablation suggest the contrary.
Whether the patchiness of the acinar b-galactosidase staining is due to a lack of fully expressivity of the Cre transgenes is unlikely, the proportions of nestin-and b-galactosidase-expressing epithelial cells are very similar in early pancreatic primordia, where b-galactosidase and nestin colocalize. Therefore, the acinar cells bearing b-galactosidase post-natally probably derive from early epithelial cells, which expressed nestin transiently (as we have shown with an anti-nestin antibody), further illustrating an heterogeneity of the exocrine pancreas that is not associated with a distinct arrangement or distribution of the X-Gal-stained acini (for instance, 'peri-' vs. 'teleinsular', Adelson and Miller, 1989) .
The expression of a neuronal progenitor marker such as nestin represents a convergence between neurons and acinar cells; in this perspective, the reported expression of acinar cell markers such as Mist1 and p48 in various neuronal cell types (Hewes et al., 2003; Obata et al., 2001 ) is noteworthy.
Our results also indicate that endocrine progenitor cells do not appear to express nestin. Esni and co-workers provide a similar conclusion in an elegant accompanying in vitro study, and Treutelaar and colleagues also report that nestin is not expressed in islet endocrine cells (Treutelaar et al., 2003) ; furthermore, studies using primary human embryonic pancreatic cells in vitro suggest similar conclusions (Humphrey et al., 2003) . If true, this fact would represent an important divergence between nerve cells and islet endocrine cells. However, several considerations must be addressed. It may be that endocrine cells arise from a fraction of nestin þ cells in which nestin expression results from cis-regulatory elements not present in the transgenes used by us and Treutelaar et al. Furthermore, Cre expression may be insufficient to tag cells in which nestin is transcribed at very low levels or for a short period of time, or both. Nevertheless, taken together, our results suggest that there is no major contribution of cells expressing nestin to the formation of the endocrine cells of the islets of Langerhans.
What may be the role of nestin-expressing cells? Previous in vitro studies suggest that nestin-expressing cells are precursors to endocrine cells: cultures of nestincontaining islet-derived cells (Zulewski et al., 2001) , or ES cells selected for the expression of nestin (Lumelsky et al., 2001) , generated islet-like structures in vitro; since no direct cell tracing analyses were performed in those experiments, nestin þ cells might act indirectly (i.e. non-cell autonomously) in such differentiation protocols. Whether different mechanisms (involving different cell types and different gene expression pathways) are implicated in the production of new b-cells in different situations, such as during development, or in the adult in pathological conditions, or in experimental protocols in vitro from ES cells (Blyszczuk et al., 2003; Lumelsky et al., 2001) or from other undifferentiated cells (Zulewski et al., 2001 ), needs to be further explored.
Anti-nestin staining confirmed that nestin-expressing cells are rare in the adult pancreas. After partial pancreatectomy, however, this is transitorily different, for there is a massive increase in the numbers of nestinexpressing endothelial cells. Others reported similar results after duct ligation, another experimental model of pancreatic injury that triggers regeneration: nestin was shown in new capillaries and in peri-acinar stellate cells, indicating that nestin is an angiogenic marker (Lardon et al., 2002) . In nestin-Cre/R26R transgenics, the temporary rise of pancreatic endothelial nestin-expressing cells after the partial ablation of the gland was not followed by a subsequent increase of the proportion of cells stained with either X-Gal or anti-b-galactosidase antibody. This indicates that the transient nestin-expressing endothelium does not represent a specific pool of islet progenitor cells, but rather a population of cells that die without leaving any labeled progeny.
Stellate cells, which are more abundant in the regenerating pancreas and liver (Kalinichenko et al., 2003; Zimmermann et al., 2002) , are a source of NGF and neurotrophins (Cassiman et al., 2001) , factors that have previously been implicated in the regulation of islet neogenesis (Scharfmann, 1997) . Nestin expression is a feature of dedifferentiation: it is re-expressed during repair processes in a variety of organs such as liver (stellate cells, Friedman, 1999; Messing, 1999; Niki et al., 1999) , teeth (odontoblasts, About et al., 2000) , muscle (myoblasts, Vaittinen et al., 2001) , or the CNS (astrocytes and endothelia, Duggal et al., 1997; Ha et al., 2002) . Expression of nestin may therefore be viewed as a trait of cells involved mainly indirectly in the genesis of new cells during regeneration, and possibly during development, not only in the pancreas but also in other organs. This could be via stellate or endothelial cells, or both, and should be of relevance in devising new protocols for cell replacement therapies in a variety of diseases.
Materials and methods
Transgenic mice
Two different nestin-Cre mice were generated independently in two different laboratories (Tronche et al., 1999; Trumpp et al., 1999) . The transgenics produced by Klein (Tronche et al., 1999) were purchased from The Jackson Laboratories (strain: B6.Cg (SJL)-TgN(NesCre)1Kln; stock #003771). Both strains bear a Cre recombinase gene under the control of the rat nestin 5 0 Flanking (5.8-kb) and 2nd intron (1.8-kb) sequences, as described (Zimmerman et al., 1994) . The ROSA26R ubiquitous reporter mice (R26R) (Soriano, 1999) were obtained from The Jackson Laboratories (strain: B6.129S4-Gtrosa26 tm1Sor ; stock #003474). Doubly transgenic animals were genotyped by PCR and/or directly with X-Gal or anti-b-galactosidase staining. The oligonucleotides used as primers yielded two fragments of 300 and 500 bp for Cre recombinase and Lac Z genes, respectively; their sequences were: 5 0 -ATGCTTC-TGTCCGTTTGCCG-3 0 /5 0 -CCTGTTTTGCACGTTCAC-CG-3 0 for Cre, and 5 0 -ACGGCAAACGACTGTCCTGG-3 0 / 5 0 -CGTGACTGGGAAAACCCTGG-3 0 for Lac Z, using a standard 30-cycle PCR profile.
X-Gal staining
Total embryos or pancreatic buds at different developmental stages, and adult pancreata, were harvested in cold phosphate buffer (pH 7.4) and fixed for 1 h at 4 8C in 4% PFA. Tissues were then incubated overnight at 37 8C in X-Gal substrate (5 mM K 4 Fe(CN) 6 , 5 mM K 3 Fe(CN) 6, 2 mM MgCl 2 , 0.01% Na deoxycholate, 0.02% NP40, 1 mg/ml X-Gal in phosphate buffer, pH 7.4). Subsequently, stained samples were embedded in paraffin, sectioned, and counterstained with hemalun, for high-resolution analyses of b-galactosidase activity.
Immunohistochemistry
Embryos at different developmental stages, and adult pancreata, were harvested in cold PBS and fixed in 4% PFA overnight at 4 8C. Then, the tissues were embedded in paraffin and 5 mm-thick tissue sections were mounted on adhesive-coated slides.
For detection of nestin and b-galactosidase, the slides were dewaxed, rehydrated and soaked in 10 mM citrate buffer (pH 6) in a microwave oven at 700 W for 10 min, and then an additional 20 min at room temperature ('antigen retrieval' procedure). When diaminobenzidine (DAB) was used to reveal the immunostaining, sections were pretreated with 3% H 2 O 2 (in PBS) for 10 min, in order to quench endogenous peroxydases. Sections were subsequently incubated with blocking reagent (5% donkey serum, 0.1% Tween, free biotin-Vector Laboratories-in PBS) for 30 min and then overnight at 4 8C with either mouse anti-rat nestin (Chemicon, clone 401, dilution 1/100) or rabbit anti-b-galactosidase (Abcam, dilution 1/250) antibody in blocking reagent (free biotin was replaced by free streptavidin), and then incubated for 1 h with biotinylated anti-mouse or anti-rabbit (Jackson Immunoresearch, dilution 1/200) antibody, respectively. Immunostaining was revealed by either immunofluorescence with streptavidin-Alexa 488 (for nestin) or 568 (for b-galactosidase) (Molecular Probes, dilution 1/100, during 1 h at room temperature), or with streptavidin-hrp (Jackson Immunoresearch, dilution 1/300, 1-h)/DAB.
The surface occupied by epithelial cells stained with X-Gal or anti-nestin antibody was measured on pancreatic sections from two embryos per developmental stage (i.e. E12.5, E15.5 and E17.5) by outline/integration using the NIH's Image J software (version 1.25).
All other antibodies were used on paraffin sections of pancreata previously stained with X-Gal. For PanK and myosin, antigen retrieval was required as well. In these protocols, non-specific binding sites were blocked by treating the sections for 30 min with 3% BSA, 0.1% Tween in PBS. Primary antibodies were then incubated for 1 h in blocking reagent. The antibodies and their dilution used in the present analysis were as follows: guinea pig antiporcine insulin (Dako, dilution 1/400), mouse anti-porcine glucagon (Sigma, dilution 1/1000), rabbit anti-human somatostatin (Sigma, dilution 1/200), rabbit anti-human PP (Bachem, 1/200), mouse anti-human PanK (Sigma, dilution 1/100), goat anti-human vimentin (Sigma, dilution 1/20), rabbit anti-PECAM (kind gift of Dr Aurrand-Lyons, University of Geneva Medical School, dilution 1/500) and mouse anti-myosin (kind gift of Dr Piallat-Bochaton, University of Geneva Medical School, at 1/20). Then, sections were washed and incubated with specific secondary antibodies coupled to Cy3 (Jackson Immunoresearch).
The specificity of the different immunostainings was confirmed by controls in which primary antibodies were omitted. Sections were examined and photographed with a Nikon epifluorescence microscope (Eclipse TE200) equipped with a Nikon CoolPix 990 digital camera, and when indicated, the specimens were analyzed using a Zeiss LSM510 confocal microscope.
Partial pancreatectomy
Partial (60%) pancreatectomy (PX) was performed in wild type C57/B6xCBA/J mice (2 month-old, Iffa Credo) for the analysis of endogenous nestin expression and on two males of each strain of nestin-Cre/R26R mice. Briefly, the pancreas was removed by gentle abrasion with cotton applicators (Q-tips), leaving intact the major blood vessels supplying other organs, as described in rats (Bonner-Weir et al., 1983) . The residual pancreas was easily defined as the tissue within 1 -2 mm of the common pancreatic duct that extends to the first part of the duodenum. Littermates of the same sex were not operated, and used as controls.
One, 3, 13 (for wild type mice) and 30 days (for the nestin-Cre/R26R) after pancreatectomy, pancreas of controls and pancreatectomized mice were collected and fixed overnight in 4% PFA, at 4 8C. Then, the tissues were embedded in paraffin and sections of 5 mm of thickness were performed and mounted on coated slides for the analysis of nestin and b-galactosidase expression, as described above.
The surface occupied by cells having b-galactosidase was measured using sections of pancreas from PX and sham-operated nestin-Cre/R26R mice that were stained using X-Gal or anti-b-galactosidase antibody. Four sections per pancreas were randomly chosen and photographed with the digital camera. Nestin-and b-galactosidase-stained areas were quantified using the NIH's Image J software. The distributions were compared using a non-parametric MannWhitney test.
